Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
565-04-010 ISMRM Abstract

Multimodal MRI Radiomics and Clinical Indicators for Predicting Short-Term Targeted Therapy Response in Locally Advanced NPC

Accepted
Zijing Lin 1, Zhiqiang Chen1, Guangxu Han2
1The First Affiliated Hospital of Hainan Medical College‌, Hainan, China
2GE HealthCare MR Research, Beijing, China
Presenting Author: Zijing Lin

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Htet H, Anaghan JRJ, Jaiprakash H, et al. Efficacy and safety of molecular targeted therapies in nasopharyngeal carcinoma: a network meta-analysis. BMC Cancer. 2025; 25(1): 1-13. https://doi.org/10.1186/s12885-025-13528-y [doi]
2. Wang Z, Feng M, Zhang J, et al. Radiomics and deep learning in nasopharyngeal carcinoma: a review. IEEE Reviews in Biomedical Engineering. 2023; 17: 118-135. https://doi.org/10.1109/RBME.2023.3269776 [doi]
3. 3Jin X, Li WZ, Guo YH, et al. Predicting progression-free survival using dynamic contrast-enhanced imaging-based radiomics in advanced nasopharyngeal carcinoma patients treated with nimotuzumab. European Radiology. 2025; [in press]: 1-11. https://doi.org/10.1007/s00330-025-11433-3 [doi]
4. 4Li Q, Yu Q, Gong B, Ning Y, Chen X, Gu J, Lv F, Peng J, Luo T. The effect of magnetic resonance imaging based radiomics models in discriminating stage I-II and III-IVa nasopharyngeal carcinoma. Diagnostics (Basel). 2023; 13(2): 300. https://doi.org/10.3390/diagnostics13020300. PMID: 36673110; PMCID: PMC9857437 [doi] [pmid]

Cite this abstract